Investors Are Moving Back Into Resurgent Biotech ETFs
December 09, 2019 at 11:10 AM EST
After stumbling through much of 2019, biotechnology ETFs are finding their grooves in the fourth quarter. Since the start of the current quarter, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB) is higher by more than 16% while the SPDR S&P Biotech ETF (NYSEArca: XBI) is up 17.40%. IBB...